{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:54:38Z","timestamp":1792173278083,"version":"4.4.0"},"reference-count":28,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The selective estrogen-receptor modulator (SERM) tamoxifen became the first U.S. Food and Drug Administration (FDA)\u2013approved agent for reducing breast cancer risk but did not gain wide acceptance for prevention, largely because it increased endometrial cancer and thromboembolic events. The FDA approved the SERM raloxifene for breast cancer risk reduction following its demonstrated effectiveness in preventing invasive breast cancer in the Study of Tamoxifen and Raloxifene (STAR). Raloxifene caused less toxicity (versus tamoxifen), including reduced thromboembolic events and endometrial cancer. In this report, we present an updated analysis with an 81-month median follow-up. STAR women were randomly assigned to receive either tamoxifen (20 mg\/d) or raloxifene (60 mg\/d) for 5 years. The risk ratio (RR; raloxifene:tamoxifen) for invasive breast cancer was 1.24 (95% confidence interval [CI], 1.05\u20131.47) and for noninvasive disease, 1.22 (95% CI, 0.95\u20131.59). Compared with initial results, the RRs widened for invasive and narrowed for noninvasive breast cancer. Toxicity RRs (raloxifene:tamoxifen) were 0.55 (95% CI, 0.36\u20130.83; P = 0.003) for endometrial cancer (this difference was not significant in the initial results), 0.19 (95% CI, 0.12\u20130.29) for uterine hyperplasia, and 0.75 (95% CI, 0.60\u20130.93) for thromboembolic events. There were no significant mortality differences. Long-term raloxifene retained 76% of the effectiveness of tamoxifen in preventing invasive disease and grew closer over time to tamoxifen in preventing noninvasive disease, with far less toxicity (e.g., highly significantly less endometrial cancer). These results have important public health implications and clarify that both raloxifene and tamoxifen are good preventive choices for postmenopausal women with elevated risk for breast cancer. Cancer Prev Res; 3(6); 696\u2013706. \u00a92010 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-10-0076","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T23:09:18Z","timestamp":1271718558000},"page":"696-706","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":549,"title":["Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer"],"prefix":"10.1158","volume":"3","author":[{"given":"Victor G.","family":"Vogel","sequence":"first","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Costantino","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Lawrence","family":"Wickerham","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Cronin","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena S.","family":"Cecchini","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Atkins","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese B.","family":"Bevers","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Fehrenbacher","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo R.","family":"Pajon","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"James L.","family":"Wade","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Robidoux","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Margolese","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"James","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn D.","family":"Runowicz","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Ganz","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Reis","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Worta","family":"McCaskill-Stevens","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie G.","family":"Ford","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Craig","family":"Jordan","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Wolmark","sequence":"additional","affiliation":[{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"},{"name":"Authors' Affiliations:\u20081National Surgical Adjuvant Breast and Bowel Project (NSABP); 2University of Pittsburgh Cancer Institute; 3NSABP Biostatistical Center; 4University of Pittsburgh Graduate School of Public Health, Department of Biostatistics; 5Allegheny General Hospital; 6University of Pittsburgh Cardiovascular Institute, Pittsburgh, Pennsylvania; 7American Cancer Society, Atlanta, Georgia; 8Southeast Cancer Control Consortium - CCOP, Winston-Salem, North Carolina; 9MD Anderson Cancer Center, Houston, Texas; 10Kaiser Permanente Northern California, Vallejo, California; 11Colorado Cancer Research Program, Denver, Colorado; 12Central Illinois CCOP, Decatur, Illinois; 13CHUM-H\u00f4tel-Dieu; 14Jewish General Hospital, McGill University, Montreal, Quebec, Canada; 15Fox Chase Cancer Center, Philadelphia, Pennsylvania; 16University of Connecticut Health Center, Farmington, Connecticut; 17Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center, University of California, Los Angeles,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the National Surgical Adjuvant Breast and Bowel Project","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2010,6,2]]},"reference":[{"key":"2022060813385362700_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"2022060813385362700_bib2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","author":"Early Breast Cancer Trialists' Collaborative Group","year":"2005","journal-title":"Lancet"},{"key":"2022060813385362700_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","article-title":"First results from the International Breast Cancer Intervention Study (IBIS-1): a randomised prevention trial","volume":"360","author":"Cuzick","year":"2002","journal-title":"Lancet"},{"key":"2022060813385362700_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0140-6736(03)12342-2","article-title":"Overview of the main outcomes in breast cancer prevention trials","volume":"361","author":"Cuzick","year":"2003","journal-title":"Lancet"},{"key":"2022060813385362700_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jnci\/djk050","article-title":"Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial","volume":"99","author":"Powles","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib7","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"2022060813385362700_bib8","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"Continuing Outcomes Relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene","volume":"96","author":"Martino","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib9","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"2022060813385362700_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models to project the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/sim.4780110611","article-title":"Applications of crude incidence curves","volume":"11","author":"Korn","year":"1992","journal-title":"Stat Med"},{"key":"2022060813385362700_bib12","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: An overview of the randomised trials","volume":"351","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"2022060813385362700_bib13","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"key":"2022060813385362700_bib14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(04)16981-X","article-title":"Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials","volume":"364","author":"Fisher","year":"2004","journal-title":"Lancet"},{"key":"2022060813385362700_bib15","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jnci\/djk049","article-title":"Long-term results of tamoxifen prophylaxis for breast cancer \u2013 96-month follow-up of the randomized IBIS-1 trial","volume":"99","author":"Cuzick","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women","volume":"355","author":"Barrett-Conner","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060813385362700_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000226637","article-title":"Phase II evaluation of Ly156758 in metastatic breast cancer","volume":"45","author":"Buzdar","year":"1998","journal-title":"Oncology"},{"key":"2022060813385362700_bib19","first-page":"4020","article-title":"The antitumor actions of keoxifene (raloxifene) and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model","volume":"47","author":"Gottardis","year":"1987","journal-title":"Cancer Res"},{"key":"2022060813385362700_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0014-2964(80)90156-5","article-title":"Evaluation of the antitumor activity of the nonsteroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model","volume":"16","author":"Jordan","year":"1980","journal-title":"Eur J Cancer"},{"key":"2022060813385362700_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/endo-113-2-463","article-title":"Inhibition of the uterotrophic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018","volume":"113","author":"Jordan","year":"1983","journal-title":"Endocrinology"},{"key":"2022060813385362700_bib22","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1200\/JCO.2008.17.5190","article-title":"The 38th David A. Karnofsky lecture: The paradoxical actions of estrogen in breast cancer\u2014survival or death?","volume":"26","author":"Jordan","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022060813385362700_bib23","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/jnci\/djj262","article-title":"Effect of Factor V Leiden and prothrombin G20210\u2192A mutations on thromboembolic risk in the National Surgical Adjuvant Breast and Bowel Project cancer prevention trial","volume":"98","author":"Abramson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/01.ATV.21.2.255","article-title":"Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect","volume":"21","author":"Cushman","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022060813385362700_bib25","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.286.18.2251","article-title":"Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P-1) Breast Cancer Prevention Trial","volume":"286","author":"King","year":"2001","journal-title":"JAMA"},{"key":"2022060813385362700_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2003.03976.x","article-title":"Effect of tamoxifen on venous thrombosis risk factors in women without cancer: The breast cancer prevention trial","volume":"120","author":"Cushman","year":"2003","journal-title":"Br J Haematol"},{"key":"2022060813385362700_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/jnci\/djj011","article-title":"Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP breast cancer prevention trial (P-1)","volume":"98","author":"Beattie","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2022060813385362700_bib28","unstructured":"Available from: http:\/\/www.nsabp.pitt.edu."}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/3\/6\/696\/2248905\/696.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/3\/6\/696\/2248905\/696.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T09:42:46Z","timestamp":1654681366000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/3\/6\/696\/6614\/Update-of-the-National-Surgical-Adjuvant-Breast"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2010,6,2]]},"published-print":{"date-parts":[[2010,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-10-0076","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22523329.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6543697","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22523329","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6543697.v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.717965864.793509582","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,1]]}}}